GLPwatch

New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has Begun.

Rev Esp Cardiol (Engl Ed) · 2016

Last updated 2026-05-28
JournalRev Esp Cardiol (Engl Ed), 2016
Citations1
Relative citation ratio0.05
NIH percentile5
Molecules
Conditions studied Type 2 Diabetes, Cardiovascular Risk Reduction

Full record and abstract on PubMed 27659856 ↗